|
Jul 29
|
Wall Street is still jittery on GLP-1s
|
|
Jul 29
|
Alzheimer’s Disease: Some trials to watch over the next year
|
|
Jul 29
|
What Will Be the Best Weight Loss Drug Stock of 2030: Eli Lilly, or Novo Nordisk?
|
|
Jul 29
|
Weight Loss Drug Stocks Just Took a Hit. Should You Buy the Stock That Caused It?
|
|
Jul 29
|
Big Pharma Rallies and Moves Past Obesity
|
|
Jul 29
|
Zacks Market Edge Highlights: LLY and NVO
|
|
Jul 28
|
Home Depot Stock Turned $1,000 Into $17.5 Million, and One of Its Founders Just Revealed His Investing Secrets to Achieve Generational Wealth
|
|
Jul 28
|
Is Eli Lilly Stock a Buy?
|
|
Jul 27
|
These 2 Growth Stocks Are Set to Soar This Summer and Beyond
|
|
Jul 27
|
Bull Market Buys: 2 Growth Stocks to Own for the Long Run
|
|
Jul 26
|
June PCE inflation print, auto earnings: Morning Brief
|
|
Jul 26
|
Is Eli Lilly's Stock in a Bubble?
|
|
Jul 26
|
Eli Lilly loses $120B in value over Viking's GLP-1 progress
|
|
Jul 26
|
Should You Invest in Novo Nordisk (NVO) Ahead of Q2 Earnings?
|
|
Jul 26
|
Prediction: This Is What Eli Lilly Stock Will Do Next
|
|
Jul 26
|
Watch These Eli Lilly Stock Price Levels as Weight-Loss Drug Competition Rises
|
|
Jul 25
|
Why Weight Loss Drug Developer Stocks Tumbled on Thursday
|
|
Jul 25
|
Lilly loses $120 billion in value as rival obesity drugs impress
|
|
Jul 25
|
Viking Therapeutics Unveils Monthly Weight-Loss Shot, Rocking Eli Lilly, Novo Nordisk
|
|
Jul 25
|
Why Viking’s Weight-Loss Drug News Is Weighing on Eli Lilly, Novo Nordisk Stocks
|